Interrelationships of ubiquinone and sterol syntheses in cultured cells of neural origin.
Ubiquinone synthesis has been studied in cultured C-6 glial and neuroblastoma cells by utilizing an inhibitor, 3-beta-(2-diethylaminoethoxy) androst-5-en-17-one hydrochloride (U18666A), of cholesterol biosynthesis. Exposure of C-6 glial cells to nanomolar quantities of U18666A caused a marked inhibition of total sterol synthesis from [14C]acetate or [3H]mevalonate within minutes. A 95% inhibition was apparent after a 3-h exposure to 200 ng/ml of U18666A. These observations, together with studies of the incorporation of radioactivity from the two precursors into cholesterol, desmosterol, lanosterol, and squalene, indicated that although the most sensitive site to inhibition by U18666A is desmosterol reduction to cholesterol, a major site of inhibition is demonstrable at a more proximal site, perhaps squalene synthetase. As a consequence of the latter inhibition, exposure of C-6 glial cells to U18666A caused a marked stimulation of incorporation of [14C]acetate or [3H]mevalonate into ubiquinone. Over a wide range of U18666A concentrations, the increase in ubiquinone synthesis was accompanied by an approximately similar decrease in total sterol synthesis. Whereas in the absence of U18666A only approximately 7% of the radioactivity incorporated from [3H]mevalonate into isoprenoid compounds was found in ubiquinone, in the presence of the drug approximately 90% of incorporated radioactivity was found in ubiquinone. The reciprocal effects of U18666A on ubiquinone and sterol syntheses were apparent also in the neuronal cells. THe data thus demonstrate a tight relationship between ubiquinone and sterol biosyntheses in cultured cells of neural origin. In such cells ubiquinone synthesis is exquisitely sensitive to the availability of isoprenoid precursors derived from the cholesterol biosynthetic pathway.
D000085:Acetates / Q000378:metabolism; D000736:Androstenes / Q000494:pharmacology; D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology; D002250:Carbon Radioisotopes; D002460:Cell Line; D005910:Glioma / Q000378:metabolism; D007700:Kinetics; D008798:Mevalonic Acid / Q000031:analogs & derivatives / Q000378:metabolism; D009447:Neuroblastoma / Q000378:metabolism; D051381:Rats; D013261:Sterols / Q000096:biosynthesis*; D014451:Ubiquinone / Q000096:biosynthesis*
D000085:Acetates; D000736:Androstenes; D000924:Anticholesteremic Agents; D002250:Carbon Radioisotopes; D013261:Sterols; D014451:Ubiquinone; C006261:3-beta-(2-(diethylamino)ethoxy)androst-5-en-17-one; C015367:mevalonolactone; D008798:Mevalonic Acid